S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

BioTime News Headlines (NYSEAMERICAN:BTX)

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume338,078 shs
Average Volume719,479 shs
Market Capitalization$148.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

BioTime (NYSEAMERICAN BTX) News Headlines

Source:
DateHeadline
Lineage Cell (LCTX) Reports Q3 Loss, Lags Revenue Estimates - NasdaqLineage Cell (LCTX) Reports Q3 Loss, Lags Revenue Estimates - Nasdaq
www.nasdaq.com - November 12 at 7:51 PM
BioTime, Inc. (NYSEAMERICAN:BTX) Receives Average Rating of "Buy" from AnalystsBioTime, Inc. (NYSEAMERICAN:BTX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - October 26 at 4:19 AM
Edited Transcript of BTX earnings conference call or presentation 8-Aug-19 8:30pm GMT - Yahoo FinanceEdited Transcript of BTX earnings conference call or presentation 8-Aug-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - August 9 at 8:35 PM
Edited Transcript of BTX earnings conference call or presentation 8-Aug-19 8:30pm GMTEdited Transcript of BTX earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 9 at 8:34 PM
BioTime (BTX) Misses Q2 EPS by 15c - StreetInsider.comBioTime (BTX) Misses Q2 EPS by 15c - StreetInsider.com
www.streetinsider.com - August 9 at 3:33 PM
BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update - StreetInsider.comBioTime Reports Second Quarter 2019 Financial Results and Provides Business Update - StreetInsider.com
www.streetinsider.com - August 8 at 8:48 PM
BioTime Announces Name Change to Lineage Cell Therapeutics - StreetInsider.comBioTime Announces Name Change to Lineage Cell Therapeutics - StreetInsider.com
www.streetinsider.com - August 1 at 3:27 PM
BioTime to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019 - Business WireBioTime to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019 - Business Wire
www.businesswire.com - August 1 at 3:27 PM
BioTime Announces Name Change to Lineage Cell Therapeutics - Yahoo FinanceBioTime Announces Name Change to Lineage Cell Therapeutics - Yahoo Finance
finance.yahoo.com - July 31 at 11:38 PM
BioTime Announces Name Change to Lineage Cell TherapeuticsBioTime Announces Name Change to Lineage Cell Therapeutics
finance.yahoo.com - July 31 at 1:35 PM
BioTime (BTX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo FinanceBioTime (BTX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
finance.yahoo.com - July 25 at 2:03 PM
BioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery System - Business WireBioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery System - Business Wire
www.businesswire.com - July 11 at 3:26 PM
BioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery System - Yahoo FinanceBioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery System - Yahoo Finance
finance.yahoo.com - July 11 at 8:28 AM
BioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery SystemBioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery System
finance.yahoo.com - July 11 at 8:28 AM
Form 4 BIOTIME INC For: Jul 01 Filed by: FARRELL STEPHEN C - StreetInsider.comForm 4 BIOTIME INC For: Jul 01 Filed by: FARRELL STEPHEN C - StreetInsider.com
www.streetinsider.com - July 4 at 6:28 AM
Form 4 BIOTIME INC For: Jul 01 Filed by: Mulroy Michael H. - StreetInsider.comForm 4 BIOTIME INC For: Jul 01 Filed by: Mulroy Michael H. - StreetInsider.com
www.streetinsider.com - July 4 at 6:28 AM
Form 4 BIOTIME INC For: Mar 19 Filed by: BAILEY DON M - StreetInsider.comForm 4 BIOTIME INC For: Mar 19 Filed by: BAILEY DON M - StreetInsider.com
www.streetinsider.com - July 4 at 6:28 AM
BioTime Conducts Sale of Shares in OncoCyte Corporation - Business WireBioTime Conducts Sale of Shares in OncoCyte Corporation - Business Wire
www.businesswire.com - July 3 at 11:25 AM
Should You Be Excited About BioTime, Inc.s (NYSEMKT:BTX) 35% Return On Equity? - Yahoo FinanceShould You Be Excited About BioTime, Inc.'s (NYSEMKT:BTX) 35% Return On Equity? - Yahoo Finance
finance.yahoo.com - June 24 at 10:00 AM
Is Forbuild SA’s (WSE:BTX) 16% ROCE Any Good?Is Forbuild SA’s (WSE:BTX) 16% ROCE Any Good?
finance.yahoo.com - June 17 at 8:57 AM
BioTime Announces Appointment of General Counsel - Business WireBioTime Announces Appointment of General Counsel - Business Wire
www.businesswire.com - May 23 at 3:27 PM
BioTime Announces Appointment of General Counsel - Yahoo FinanceBioTime Announces Appointment of General Counsel - Yahoo Finance
finance.yahoo.com - May 22 at 3:24 PM
Don't Sell Forbuild SA (WSE:BTX) Before You Read ThisDon't Sell Forbuild SA (WSE:BTX) Before You Read This
finance.yahoo.com - May 15 at 5:41 AM
Edited Transcript of BTX earnings conference call or presentation 9-May-19 8:30pm GMT - Yahoo FinanceEdited Transcript of BTX earnings conference call or presentation 9-May-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - May 10 at 3:13 PM
BioTime Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued Development of OpRegen® - Yahoo FinanceBioTime Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued Development of OpRegen® - Yahoo Finance
finance.yahoo.com - May 10 at 3:13 PM
BioTime Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued Development of OpRegen®BioTime Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued Development of OpRegen®
finance.yahoo.com - May 10 at 3:13 PM
Edited Transcript of BTX earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of BTX earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 3:13 PM
BioTime Reports First Quarter 2019 Financial Results and Provides Business Update - Yahoo FinanceBioTime Reports First Quarter 2019 Financial Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - May 10 at 6:23 AM
BioTime (BTX) Tops Q1 Earnings and Revenue Estimates - Yahoo FinanceBioTime (BTX) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 10 at 6:23 AM
BioTime, Inc. (BTX) CEO Brian Culley on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaBioTime, Inc. (BTX) CEO Brian Culley on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 10 at 6:23 AM
BioTime (BTX) Tops Q1 Earnings and Revenue EstimatesBioTime (BTX) Tops Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 10 at 6:23 AM
BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury - Yahoo FinanceBioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury - Yahoo Finance
finance.yahoo.com - May 7 at 7:36 AM
BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury - Business WireBioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury - Business Wire
www.businesswire.com - May 6 at 8:17 AM
BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord InjuryBioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury
finance.yahoo.com - May 6 at 8:17 AM
BioTime to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019 - Business WireBioTime to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019 - Business Wire
www.businesswire.com - May 4 at 3:22 PM
BioTime (BTX) Highlights Updated Data from OpRegen Phase I/IIa Clinical Study at 2019 ARVO Meetings - StreetInsider.comBioTime (BTX) Highlights Updated Data from OpRegen Phase I/IIa Clinical Study at 2019 ARVO Meetings - StreetInsider.com
www.streetinsider.com - May 2 at 3:28 PM
Will BioTime (BTX) Report Negative Q1 Earnings? What You Should Know - Yahoo FinanceWill BioTime (BTX) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
finance.yahoo.com - May 2 at 3:28 PM
BioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference - Business WireBioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference - Business Wire
www.businesswire.com - April 28 at 3:19 PM
Stem Cell Market Analysis & Outlook 2019-2025 with Osiris Therapeutics, Celgene Corp, Biotime, Cynata, Advanced Cell Technology, and Stemcell Technologies Dominating - GlobeNewswireStem Cell Market Analysis & Outlook 2019-2025 with Osiris Therapeutics, Celgene Corp, Biotime, Cynata, Advanced Cell Technology, and Stemcell Technologies Dominating - GlobeNewswire
www.globenewswire.com - April 27 at 7:40 AM
Stem Cell Market Analysis & Outlook 2019-2025 with Osiris Therapeutics, Celgene Corp, Biotime, Cynata, Advanced Cell Technology, and Stemcell Technologies Dominating - Yahoo FinanceStem Cell Market Analysis & Outlook 2019-2025 with Osiris Therapeutics, Celgene Corp, Biotime, Cynata, Advanced Cell Technology, and Stemcell Technologies Dominating - Yahoo Finance
finance.yahoo.com - April 26 at 8:35 AM
BioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference - Yahoo FinanceBioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference - Yahoo Finance
finance.yahoo.com - April 26 at 8:35 AM
BioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair ConferenceBioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference
finance.yahoo.com - April 26 at 8:35 AM
Did Changing Sentiment Drive BioTimes (NYSEMKT:BTX) Share Price Down A Worrying 58%? - Yahoo FinanceDid Changing Sentiment Drive BioTime's (NYSEMKT:BTX) Share Price Down A Worrying 58%? - Yahoo Finance
finance.yahoo.com - April 24 at 3:23 PM
Did Changing Sentiment Drive BioTime's (NYSEMKT:BTX) Share Price Down A Worrying 58%?Did Changing Sentiment Drive BioTime's (NYSEMKT:BTX) Share Price Down A Worrying 58%?
finance.yahoo.com - April 24 at 3:23 PM
BioTime to Present Data from OpRegen® Phase I/IIa Clinical Study at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019) - businesswire.comBioTime to Present Data from OpRegen® Phase I/IIa Clinical Study at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019) - businesswire.com
www.businesswire.com - April 18 at 3:23 PM
BioTime to Present Data from OpRegen® Phase I/IIa Clinical Study at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019)BioTime to Present Data from OpRegen® Phase I/IIa Clinical Study at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019)
finance.yahoo.com - April 16 at 3:22 PM
BioTime (BTX) Upgraded to Strong Buy: Here's What You Should KnowBioTime (BTX) Upgraded to Strong Buy: Here's What You Should Know
finance.yahoo.com - April 12 at 3:23 PM
New Research Coverage Highlights BioMarin Pharmaceutical, EnLink Midstream, GCI Liberty, Vistra Energy, BioTime, and Karyopharm Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2019 - GlobeNewswireNew Research Coverage Highlights BioMarin Pharmaceutical, EnLink Midstream, GCI Liberty, Vistra Energy, BioTime, and Karyopharm Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2019 - GlobeNewswire
globenewswire.com - April 10 at 11:11 AM
Top Ranked Momentum Stocks to Buy for April 2nd - NasdaqTop Ranked Momentum Stocks to Buy for April 2nd - Nasdaq
www.nasdaq.com - April 2 at 3:20 PM
BioTime to Present at Oppenheimer & Co. 29th Annual Healthcare Conference on March 20, 2019BioTime to Present at Oppenheimer & Co. 29th Annual Healthcare Conference on March 20, 2019
finance.yahoo.com - March 18 at 8:39 AM
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel